Elizabeth Hurlburt
2022
In 2022, Elizabeth Hurlburt earned a total compensation of $844.8K as Executive Vice President and Head of Clinical Operations at CorMedix, a 26% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $175,623 |
|---|---|
| Option Awards | $305,900 |
| Salary | $346,346 |
| Other | $16,942 |
| Total | $844,811 |
Hurlburt received $346.3K in salary, accounting for 41% of the total pay in 2022.
Hurlburt also received $175.6K in non-equity incentive plan, $305.9K in option awards and $16.9K in other compensation.
Rankings
In 2022, Elizabeth Hurlburt's compensation ranked 3,385th out of 5,756 executives tracked by ExecPay. In other words, Hurlburt earned more than 41.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,385 out of 5,756 | 41st |
Division Manufacturing | 1,916 out of 3,133 | 39th |
Major group Chemicals And Allied Products | 913 out of 1,419 | 36th |
Industry group Drugs | 854 out of 1,320 | 35th |
Industry Pharmaceutical Preparations | 621 out of 966 | 36th |
Source: SEC filing on September 13, 2023.
Hurlburt's colleagues
We found four more compensation records of executives who worked with Elizabeth Hurlburt at CorMedix in 2022.